Home News Artisan Healthcare Consulting Strengthens Leadership Team With Promotion of Two New Partners;

Artisan Healthcare Consulting Strengthens Leadership Team With Promotion of Two New Partners;


Artisan Healthcare Consulting, Inc., a leading life-sciences strategy consulting firm, declared recently that Brad Payne and Greg Wolfe have been promoted to Partner in recognition of their outstanding contributions to client successes and because of their commitment to the professional development of Artisan’s growing team.

The appointments deepen the ability of Artisan to provide meaningful, transformative insights to our medical device and pharma/biotech clients.

“Brad and Greg have a proven track record of delivering exceptional insights and results to our clients,” said Bob Delise, President of Artisan.  “Their business talent, commitment to their clients’ success, and focus on developing the next generation of Artisan leaders has been foundational to our growth.   I look forward to working with them both to enhance Artisan’s capabilities and to accelerate our expansion to the next level.”

Brad and Greg will be responsible for growing Artisan’s business, enabling the success of existing and new clients, influencing clients’ agendas by recognizing new trends, and delivering original solutions that make a difference.

Brad Payne advises large pharmaceutical, medical device, and biotechnology companies across many therapeutic areas on commercialization, new product development, and licensing & acquisitions.  His practice includes new product strategy, portfolio planning and prioritization, differentiation of pipeline and marketed products, market assessment and benchmarking, and BD&L support.

Greg Wolfe advises pharmaceutical and biotech companies by marrying competitive intelligence, market data, and patient- and physician-level claims to deepen clients’ understanding of their customers, develop winning strategies, and plan the actions needed to execute their vision.

He has deep therapeutic expertise and has led numerous projects in oncology and immuno-oncology, immunology, infectious disease, and rare diseases.